CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Trial Evaluating the Safety and Tolerability of Intratumoral Injections of NanoPac® With Standard of Care Therapy in Subjects With Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04314895
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:46.374238+00:00
Published At: 2025-05-23T00:00:00+00:00
Record Updated At: 2025-05-23
Results Posted At: 2025-05-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lung Cancer, Nonsmall Cell", "Lung Cancer", "Lung Cancer, Small Cell", "Neoplasm of Lung"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-23"
protocolSection.identificationModule.nctId: "NCT04314895"
protocolSection.identificationModule.officialTitle: "Phase 2 Trial Evaluating the Safety and Tolerability of Intratumoral Injections of NanoPac\u00ae With Standard of Care Therapy in Subjects With Lung Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-05-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.